» Articles » PMID: 35300641

Nomogram Based on Clinical and Laboratory Characteristics of Euploid Embryos Using the Data in PGT-A: a Euploid-prediction Model

Overview
Publisher Biomed Central
Date 2022 Mar 18
PMID 35300641
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The evaluation of embryo morphology may be inaccurate. A euploid prediction model is needed to provide the best and individualized counseling about embryo selection based on patients and embryo characteristics.

Methods: Our objective was to develop a euploid-prediction model for evaluating blastocyst embryos, based on data from a large cohort of patients undergoing pre-implantation genetic testing for aneuploidy (PGT-A). This retrospective, single-center cohort study included data from 1610 blastocysts which were performed PGT-A with known genetic outcomes. The study population was divided into the training and validation cohorts in a 3:1 ratio. The performance of the euploid-prediction model was quantified using the area under the receiver operating characteristic (ROC) curve (AUC). In addition, a nomogram was drawn to provide quantitative and convenient tools in predicting euploid.

Results: We developed a reliable euploid-prediction model and can directly assess the probability of euploid with the AUC (95%CI) of 0.859 (0.834,0.872) in the training cohort, and 0.852 (0.831,0.879) in the validation cohort, respectively. The euploid-prediction model showed sensitivities of 0.903 and specificities of 0.578.

Conclusions: The euploid-prediction model is a reliable prediction model and can directly assess the probability of euploid.

Citing Articles

Impact of blastocyst biopsy for preimplantation genetic testing on maternal and neonatal outcomes following single frozen embryo transfer cycles.

He T, Shi W, Xue X, Shi J BMC Pregnancy Childbirth. 2025; 25(1):74.

PMID: 39871174 PMC: 11770986. DOI: 10.1186/s12884-024-07107-5.


Preimplantation genetic testing in couples with balanced chromosome rearrangement: a four-year period real world retrospective cohort study.

Zhou F, Ren J, Li Y, Keqie Y, Peng C, Chen H BMC Pregnancy Childbirth. 2024; 24(1):86.

PMID: 38280990 PMC: 10821259. DOI: 10.1186/s12884-023-06237-6.

References
1.
Kovacs P, Matyas S, Forgacs V, Sajgo A, Molnar L, Pribenszky C . Non-invasive embryo evaluation and selection using time-lapse monitoring: Results of a randomized controlled study. Eur J Obstet Gynecol Reprod Biol. 2018; 233:58-63. DOI: 10.1016/j.ejogrb.2018.12.011. View

2.
Chen M, Wei S, Hu J, Quan S . Can Comprehensive Chromosome Screening Technology Improve IVF/ICSI Outcomes? A Meta-Analysis. PLoS One. 2015; 10(10):e0140779. PMC: 4607161. DOI: 10.1371/journal.pone.0140779. View

3.
Khemasuwan D, Sorensen J, Griffin D . Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema. Chest. 2018; 154(3):550-556. DOI: 10.1016/j.chest.2018.01.037. View

4.
Deo R . Machine Learning in Medicine. Circulation. 2015; 132(20):1920-30. PMC: 5831252. DOI: 10.1161/CIRCULATIONAHA.115.001593. View

5.
Vera-Rodriguez M, Chavez S, Rubio C, Pera R, Simon C . Prediction model for aneuploidy in early human embryo development revealed by single-cell analysis. Nat Commun. 2015; 6:7601. PMC: 4506544. DOI: 10.1038/ncomms8601. View